Current position:Home >Product >
beta-D-Glucopyranoside, (3beta,5beta)-spirostan-3-yl O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)]-
beta-D-Glucopyranoside, (3beta,5beta)-spirostan-3-yl O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)]-(266997-53-9)
- Name: beta-D-Glucopyranoside, (3beta,5beta)-spirostan-3-yl O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)]-
- Synonyms:266997-53-9;Schidigerasaponin D1;beta-D-Glucopyranoside, (3beta,5beta)-spirostan-3-yl O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)]-;CHEMBL450450;(25RS)-Schidegera saponin D1;DTXSID401308700
- Molecular Formula:C44H72O17
- Molecular Weight:873.0
- CAS Registry Number:266997-53-9
- EINECS:
- Melting Point:
- Water Solubility:

Other Product
- 217962-29-3/(4alpha)-8-(beta-D-Glucopyranosyloxy)-p-menthane-1alpha,7-diol
- 172875-99-9/1-[(2'-Carboxy-1,1'-biphenyl-4-yl)methyl]-2-propyl-1H-imidazole-4-carboxylic acid
- 183723-10-6/Nqdbfdsohovhqu-uhfffaoysa-N
- 255833-55-7/Lepidiumsesterterpenol
- 177093-59-3/Butyric acid 4-[2-oxo-7-(diethylamino)-3-chromen-3-yl]benzyl ester
- 252990-06-0/(S)-3-{[(R)-1-((E)-3-Piperidin-4-yl-acryloyl)-pyrrolidine-3-carbonyl]-amino}-3-pyridin-3-yl-propionic acid
- 288627-09-8/Annoglabasin C
- 242145-72-8/3-[1-(4-Chlorophenyl)-5-methyl-1H-1,2,3-triazol-4-yl]-6-(4-fluorophenyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazole
- 203395-83-9/7-[4-[4-(4-Chlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone
- 303113-08-8/6H-Dibenzo(b,d)pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,8,9,10,10a-hexahydro-1-hydroxy-6-(3-hydroxy-1-propynyl)-6-methyl-, (6R,6aR,9R,10aR)-rel-
- 175522-05-1/fellutanine B
- 211486-17-8/3beta-Hydroxy-5,9-epidioxy-5alpha-ergost-7-en-6-one
- 211108-54-2/rel-(3R,4R)-3-Fluoro-N-methyl-N-(phenylmethyl)-1-[3-[5-(4H-1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]-4-piperidinamine
- 243449-55-0/(22E)-23-Methyl-5alpha-ergosta-7,22-diene-3beta,5,6beta,9-tetrol
- 154413-62-4/(E)-3-[6-(2,6-Dichloro-phenylsulfanylmethyl)-3-(3-phenyl-propoxy)-pyridin-2-yl]-acrylic acid
- 118046-33-6/Carbamic acid, [2-(1-piperidinyl)ethyl]-, 3-ethenyldodecahydro-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho[2,1-b]pyran-5-yl ester, [3R-(3alpha,4abeta,5beta,6beta,6aalpha,10alpha,10abeta,10balpha)]-
- 1008752-06-4/(1S,4R,9Z,13R,13aS,20aR,21aS)-2,3,5,6,7,8,11,12,13,13a,16,17,19,20,20a,21-Hexadecahydro-13-hydroxy-24-(8-hydroxy-9H-pyrido[3,4-b]indol-1-yl)-1,13-etheno-4,21a-methano-1H-azocino[1',2':1,5]pyrrolo[3,2-e]azacyclopentadecin-18(15H)-one
- 173740-43-7/Kaempferol 3-gentiobioside-7-rhamnoside
- 174176-91-1/1-O-beta-GLUCOPYRANOSYL-(2S,3R,4E,8Z)-2-N-((2'R)-HYDROXYICOSANOYL)-4,8-SPHINGADIENINE
- 266997-53-9/beta-D-Glucopyranoside, (3beta,5beta)-spirostan-3-yl O-beta-D-glucopyranosyl-(1-->2)-O-[beta-D-xylopyranosyl-(1-->3)]-
- 171527-63-2/Brevetoxin B3 C64 component
- 333333-20-3/Goyasaponin I
- 205311-55-3/2-Methyl-5-(methylthio)-1H-imidazole
- 167371-38-2/5-ethylpyrazolo[1,5-a]pyrimidin-7(4H)-one
- 161416-99-5/3-[[(2S)-1-Methyl-2-azetidinyl]methoxy]pyridine
- 212516-43-3/Verimol J
- 219872-99-8/4-[(1E,3E)-5-Oxo-1,3-pentadienyl]benzonitrile
- 141434-49-3/5alpha-Ethylhexahydro-2,6-dioxo-4alpha-pyrimidinecarboxylic acid
- 176896-61-0/(1R,4R,6R)-1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octane-4,6-diol
- 254102-05-1/(3S)-N-methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide